Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
about
Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomasEmergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsLive imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammationCross-species oncogenomics using zebrafish models of cancerA high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafishDeriving cell lines from zebrafish embryos and tumorsA fully automated robotic system for microinjection of zebrafish embryosCross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcomaA DNA transposon-based approach to validate oncogenic mutations in the mouseLineage of origin in rhabdomyosarcoma informs pharmacological responseOptimized cell transplantation using adult rag2 mutant zebrafish.c-Myc is required for maintenance of glioma cancer stem cells.Zebrafish as a model for cancer self-renewalTargeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcomaMouse models for cancer stem cell research.MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis.Spatio-temporal regulation of Wnt and retinoic acid signaling by tbx16/spadetail during zebrafish mesoderm differentiation.Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia.Somatic mutagenesis with a Sleeping Beauty transposon system leads to solid tumor formation in zebrafish.Zebrafish models of p53 functions.SIGNATURE: a workbench for gene expression signature analysis.The zebrafish as a model for cancer.Animal models of soft-tissue sarcoma.Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish.Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.Understanding kidney disease: toward the integration of regulatory networks across species.Zebrafish cancer: the state of the art and the path forward.Rhabdomyosarcoma: current challenges and their implications for developing therapies.Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafishEvidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaThe histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish.Small molecule screening in zebrafish: swimming in potential drug therapies.Comparative oncogenomic analysis of copy number alterations in human and zebrafish tumors enables cancer driver discoveryIdentification of candidate B-lymphoma genes by cross-species gene expression profiling.Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated stateOncogenic KRAS promotes malignant brain tumors in zebrafish.Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene deliveryNormal and malignant muscle cell transplantation into immune compromised adult zebrafish.Aberrant AKT activation drives well-differentiated liposarcoma
P2860
Q26825000-D11042D7-A352-41A2-BD68-8B9657C21599Q26860518-666B9E2B-03A2-4A24-8433-DBC5549B0586Q27322639-76A70449-C1DE-485F-BAE9-AB143501B7FBQ28087440-6B340A35-4DC3-4E01-B5CA-82F246E02B28Q28393439-B6D6D367-CD20-46DA-89CA-43109E41A971Q28468683-7EF3F324-65BF-4DAC-A038-29FA7C361B08Q28469293-DDB3CEF9-8812-4846-A64F-FFD77AD60710Q28536066-3C9BDD88-B804-4E62-9D28-B9CDAB4858ACQ28756297-107C485A-ED1B-436F-A9AD-2BA3CC873A41Q30411722-3646D453-98B6-498E-A2AB-30E872C4800AQ30615497-66EA9728-0F6D-498B-99F1-0FE0F6476EA4Q33385645-5B57C4A7-9D75-48F9-BF17-D131A59FCCF1Q33584755-492347DB-216B-4563-A443-D6874CA8C87AQ33586736-0ED3C55E-5D71-4BE1-B962-3E56DE251757Q33684472-E693EE59-9502-4216-A4BF-2C536FAE9FD7Q33688560-B3F1656E-FD7B-47C1-A206-332519415724Q33688568-6569FD4E-74A2-4953-9BF6-C25F1161DD31Q33800135-0C8208DA-399B-4372-A9EC-89E4B81E7CE7Q33806080-CAE7D05D-E15E-4E93-AAE8-2D7387F3DD51Q33885998-250B9A90-C2F8-4C0D-8192-2A0897DBFD03Q34014685-4078CBA6-3369-4897-8F39-D33D80827CDDQ34073164-F07C0758-EEA3-4FDB-88C2-19495EC61ED3Q34098103-8D3F3B5A-C670-4FA3-9174-23F2D588FA74Q34098113-AC5D24D0-E332-434B-B666-0AB589154790Q34144327-633E2B2C-72E4-4BBE-A7D3-C8A72B6CB281Q34248627-841B9188-B1C8-4A3C-B5B8-B212CA0514D9Q34340510-D765CC0E-6E7C-4644-8305-68F54CB9E063Q34366010-CA8EF913-571D-4972-808C-B444BF28B3DBQ34400242-E64B8F19-C716-4642-B6EC-AC4DAC232BF9Q34523445-6E76E9AB-A933-4214-BDA2-9F38028294E1Q34580128-5F4A128D-05C9-42DC-A814-1B7C83F7C411Q34738256-77C42185-8820-42BF-BE41-6CA2F96BEF32Q34784242-FC49711B-EA9B-4501-9D31-8824BCD62542Q34979403-89C5A84C-AD33-4EED-BDEE-9764B755DBD3Q35018604-32C35A12-91FA-4BD1-9BFC-910790DEDEE9Q35022234-7C7FC2CA-3E83-42B0-A082-F7779BE1E32DQ35061277-3FE63631-C187-423E-8D46-73935B286A4DQ35148115-08E7C150-CC03-4C03-83F1-3E84BD9F32D6Q35161809-2F371253-A3C6-4BA9-9E82-6C2A91E54BA3Q35239698-512DEBDC-70AA-48AE-B2FD-C15D30DB19D8
P2860
Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
@en
type
label
Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
@en
prefLabel
Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
@en
P2093
P2860
P356
P1433
P1476
Effects of RAS on the genesis of embryonal rhabdomyosarcoma
@en
P2093
David M Langenau
Donna S Neuberg
Jeffery L Kutok
Jeffrey R Guyon
Leonard I Zon
Louis M Kunkel
Matthew D Keefe
Narie Y Storer
Xiuning Le
P2860
P304
P356
10.1101/GAD.1545007
P577
2007-05-17T00:00:00Z